XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.25.3

ACCRUED LIABILITIES (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Payables and Accruals [Abstract] |
Schedule of Accrued Liabilities | Accrued liabilities consisted of the following as of September 30, 2025 and December 31, 2024:
(In thousands) |  | SEPTEMBER 30, 2025 |  | DECEMBER 31, 2024
CRO and clinical trial costs |  | $ | 6,263 |  |  | $ | 18,968 |
Manufacturing activities |  | 26,169 |  |  | 11,839 |
Professional legal and accounting fees |  | 963 |  |  | 475 |
Interest payable |  | — |  |  | 2,186 |
Gross-to-net adjustments |  | 4,105 |  |  | 1,166 |
Other |  | 2,428 |  |  | 915 |
Total Accrued Liabilities |  | $ | 39,928 |  |  | $ | 35,549 |

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration